Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's the Outlook for Arbutus Biopharma?

TheMotleyFool

0 0

What's the Outlook for Arbutus Biopharma?

Like many biotech stocks, Arbutus Biopharma (NASDAQ: ABUS) has been a loser for investors over the past 12 months. In this Motley Fool Live video, recorded on Jan. 26, Fool contributors Keith Speights and Brian Orelli address a viewer's question about the stock.

Source Fool.com

Like: 0

ABUS

Share